Credit Suisse’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $2.91M | Buy |
59,198
+22,179
| +60% | +$1.09M | ﹤0.01% | 1612 |
|
2023
Q4 | $1.35M | Buy |
37,019
+3,589
| +11% | +$131K | ﹤0.01% | 2139 |
|
2023
Q3 | $773K | Sell |
33,430
-12,188
| -27% | -$282K | ﹤0.01% | 2441 |
|
2023
Q2 | $1.2M | Buy |
45,618
+13,379
| +41% | +$351K | ﹤0.01% | 2252 |
|
2023
Q1 | $830K | Buy |
32,239
+8,703
| +37% | +$224K | ﹤0.01% | 2430 |
|
2022
Q4 | $612K | Sell |
23,536
-2,392
| -9% | -$62.2K | ﹤0.01% | 2644 |
|
2022
Q3 | $741K | Buy |
25,928
+6,418
| +33% | +$183K | ﹤0.01% | 2523 |
|
2022
Q2 | $480K | Buy |
19,510
+566
| +3% | +$13.9K | ﹤0.01% | 2857 |
|
2022
Q1 | $1.07M | Buy |
18,944
+1,597
| +9% | +$90K | ﹤0.01% | 2487 |
|
2021
Q4 | $1.08M | Buy |
17,347
+2,538
| +17% | +$157K | ﹤0.01% | 2538 |
|
2021
Q3 | $939K | Buy |
14,809
+2,367
| +19% | +$150K | ﹤0.01% | 2624 |
|
2021
Q2 | $1.03M | Sell |
12,442
-1,047
| -8% | -$86.3K | ﹤0.01% | 2612 |
|
2021
Q1 | $993K | Sell |
13,489
-22,264
| -62% | -$1.64M | ﹤0.01% | 2582 |
|
2020
Q4 | $2.59M | Buy |
35,753
+10,681
| +43% | +$775K | ﹤0.01% | 1961 |
|
2020
Q3 | $1.2M | Buy |
25,072
+14,879
| +146% | +$710K | ﹤0.01% | 2151 |
|
2020
Q2 | $428K | Buy |
+10,193
| New | +$428K | ﹤0.01% | 2782 |
|
2019
Q4 | – | Sell |
-27,319
| Closed | -$592K | – | 3569 |
|
2019
Q3 | $592K | Buy |
+27,319
| New | +$592K | ﹤0.01% | 2712 |
|